13 January 2012 - US Advanced BioNutrition Corp said yesterday it had inked global agreement with Santiago-based animal health and veterinary pharmaceuticals company Centrovet Laboratories to expand the delivery of oral vaccines aimed to prevent the Infectious Salmon Anemia Virus (ISAV) and, possibly, other diseases in salmonid species.

The vaccine is delivered via commercial salmon feed by means of patented delivery systems of the US firm.

The agreement represents the first global expansion of ABN's technologies and the first international venture of the Chilean company.

The partnership between the two firms started in March 2009 when Centrovet received a registration for a freeze-dried, oral-powder vaccine to aid in the prevention of Salmon Rickettsial Syndrome (SRS) in Chilean salmonid species.

The Advanced BioNutrition's technology allows commercial fish farmers to deliver the antigen inducing an effective immune response in salmonid species. This oral vaccine will be further applied in Norway, the Faroe Islands, Scotland, the US and Canada.